Research

Hormonal

Tirzepatide (Mounjaro/Zepbound) is a dual GIP/GLP-1 receptor agonist that promotes weight loss and glycemic control through synergistic mechanisms including increased glucose-dependent insulin secretion, reduced glucagon, delayed gastric emptying, and increased satiety.

Tirzepatide is a powerful, weekly injectable medication for diabetes and obesity that works by mimicking hormones to control blood sugar and reduce appetite. It requires a prescription, medical supervision, and lifestyle changes (diet/exercise). Using it without medical oversight for aesthetic reasons is dangerous and contributes to drug shortages and fraud.

GoodSupportsHIGH confidence
Trata-se de um agonista de ação prolongada com afinidade pelos receptores de GIP e GLP-1, mecanismo que contribui para aumento da secreção de insulina dependente da glicose, redução do glucagon, retardo do esvaziamento gástrico e aumento da saciedade (ANVISA, 2026).
Lucas Andrade Menezes et al. · Revista Multidisciplinar do Nordeste Mineiro · 2026

Why this rating

Based on regulatory documents (ANVISA, FDA) and clinical trial data cited in a narrative review.

Source

USO INDISCRIMINADO DE MOUNJARO E CIRCULAÇÃO DE PRODUTOS DE ORIGEM DUVIDOSA COMO EXPRESSÃO DE CRISE SANITÁRIA NA SAÚDE COLETIVA

Lucas Andrade Menezes et al. · Revista Multidisciplinar do Nordeste Mineiro · 2026

DOI 10.66104/qc09as49

narrative_reviewCited 2×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →